| Kelly Pappas, | |
|
1900 Sunset Blvd, West Columbia, SC 29169-5959 | |
| (802) 250-6833 | |
| (803) 693-0850 |
| Full Name | Kelly Pappas |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1900 Sunset Blvd, West Columbia, South Carolina |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265808711 | NPI | - | NPPES |
| 5613 | Other | SC | SLP LICENSURE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 5613 (South Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kelly Pappas, 1900 Sunset Blvd, West Columbia, SC 29169-5959 Ph: (802) 250-6833 | Kelly Pappas, 1900 Sunset Blvd, West Columbia, SC 29169-5959 Ph: (802) 250-6833 |
News Archive
AMRI today announced it received a federal contract award from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to provide chemistry and other drug discovery technologies in support of NINDS' Medicinal Chemistry for Neurotherapeutics Program (MCNP), part of the NIH Blueprint Neurotherapeutics Network.
Americans may like their drinks "sickeningly sweet" but a new labeling initiative may discourage us from pouring on the unnecessary calories, said Jessica Bartfield, MD, medical weight-loss specialist at Gottlieb Memorial Hospital.
Ventria Bioscience has announced the successful completion of a phase 2 clinical trial of its lead therapeutic candidate, VEN100. The study was conducted by a team of investigators from the Department of Epidemiology, Division of Infectious Diseases, and Division of Geriatric Medicine at Johns Hopkins University.
Publishing in the current issue of The Journal of Biological Chemistry (Vol. 286, No 43), researchers at Moffitt Cancer Center in Tampa, Fla., have discovered additional mechanisms of "Akt" activation and suggest a component of that activation mechanism - inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE) - could be targeted as a therapeutic intervention for treating cancer.
› Verified 9 days ago
Erin M Bennett, MSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 103 Hospital Dr W, West Columbia, SC 29169 Phone: 803-794-5437 Fax: 803-794-5437 | |
Sara Walden Hanna, MSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2720 Sunset Blvd, West Columbia, SC 29169 Phone: 803-791-2155 | |
Jessica Schumpert Floyd, MSP, CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2993 Sunset Blvd, West Columbia, SC 29169 Phone: 803-939-0026 | |
Mrs. Carol Demontmollin Jennings, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 Springcreek Ct, West Columbia, SC 29170 Phone: 803-356-0449 Fax: 803-808-3873 | |
Loretta B Spencer, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3937 Sunset Blvd Ste B, West Columbia, SC 29169 Phone: 803-900-4890 Fax: 803-931-3891 | |
Communicare, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 151 Drayton Hall Dr, West Columbia, SC 29172 Phone: 803-587-5810 | |
Dr. Tracy L. Johnson, ED.D. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2700 Feather Run Trl, Apt. E20, West Columbia, SC 29169 Phone: 803-926-3699 |